Search research articles
Contact Us
Filters
Showing results (501-510 of 512) with videos related to
Page
of 52
Sort By:
Cancer Discovery
|
April 9, 2025
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements
Seshiru Nakazawa, Federica Pecci, Igor Odintsov, et al.
The New England Journal of Medicine
|
September 9, 2025
Overall Survival with Amivantamab-Lazertinib in <i>EGFR</i>-Mutated Advanced NSCLC
James Chih-Hsin Yang, Shun Lu, Hidetoshi Hayashi, et al.
Oncotarget
|
May 7, 2015
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer
Vladimir Lazar, Eitan Rubin, Stephane Depil, et al.
Cancer Discovery
|
August 5, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer
Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, et al.
The New England Journal of Medicine
|
June 26, 2024
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i>-Mutated Advanced NSCLC
Byoung C Cho, Shun Lu, Enriqueta Felip, et al.
Cell Reports
|
August 3, 2012
Prognostic impact of vitamin B6 metabolism in lung cancer
Lorenzo Galluzzi, Ilio Vitale, Laura Senovilla, et al.
Science (New York, N.Y.)
|
June 8, 2023
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Marine Fidelle, Conrad Rauber, Carolina Alves Costa Silva, et al.
Cancers
|
August 26, 2022
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
Oskar Wysocki, Cong Zhou, Jacobo Rogado, et al.
JCO Clinical Cancer Informatics
|
May 24, 2022
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
Rebecca J Lee, Oskar Wysocki, Cong Zhou, et al.
Nature Genetics
|
September 4, 2012
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer, Lynnette Fernández-Cuesta, Martin L Sos, et al.
Page
of 52
Search research articles
Search
Showing results (501-510 of 512) with videos related to
Sort By:
Page
of 52
Cancer Discovery
|
April 9, 2025
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements
Seshiru Nakazawa, Federica Pecci, Igor Odintsov, et al.
The New England Journal of Medicine
|
September 9, 2025
Overall Survival with Amivantamab-Lazertinib in <i>EGFR</i>-Mutated Advanced NSCLC
James Chih-Hsin Yang, Shun Lu, Hidetoshi Hayashi, et al.
Oncotarget
|
May 7, 2015
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer
Vladimir Lazar, Eitan Rubin, Stephane Depil, et al.
Cancer Discovery
|
August 5, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer
Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, et al.
The New England Journal of Medicine
|
June 26, 2024
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i>-Mutated Advanced NSCLC
Byoung C Cho, Shun Lu, Enriqueta Felip, et al.
Cell Reports
|
August 3, 2012
Prognostic impact of vitamin B6 metabolism in lung cancer
Lorenzo Galluzzi, Ilio Vitale, Laura Senovilla, et al.
Science (New York, N.Y.)
|
June 8, 2023
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Marine Fidelle, Conrad Rauber, Carolina Alves Costa Silva, et al.
Cancers
|
August 26, 2022
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
Oskar Wysocki, Cong Zhou, Jacobo Rogado, et al.
JCO Clinical Cancer Informatics
|
May 24, 2022
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
Rebecca J Lee, Oskar Wysocki, Cong Zhou, et al.
Nature Genetics
|
September 4, 2012
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer, Lynnette Fernández-Cuesta, Martin L Sos, et al.
Page
of 52